Sigma Planning’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.5M Sell
20,100
-50
-0.2% -$3.68K 0.04% 441
2026
Q2
$1.29M Buy
+20,150
New +$1.05M 0.03% 501

Other funds holding KNSA

Sigma Planning's KNSA Position: Q3 2026 in Review

Sigma Planning reduced its Kiniksa Pharmaceuticals (KNSA) stake by 0.25% in Q3 2026, selling an estimated $3.68K and leaving 20,100 shares worth $1.5M. The position accounts for 0.04% of the portfolio, ranked #441.

Sigma Planning first reported a position in KNSA in Q2 2026 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Sigma Planning held 20,100 shares of Kiniksa Pharmaceuticals worth $1.5M as of Q3 2026.
  • Sigma Planning sold 50 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $3.68K.
  • Kiniksa Pharmaceuticals made up 0.04% of Sigma Planning's portfolio in Q3 2026, its #441 holding.
  • Sigma Planning first reported a position in Kiniksa Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.